We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
News and media menu
Published date
- October 2025 (2)
- September 2025 (1)
- July 2025 (1)
- June 2025 (2)
- May 2025 (1)
- March 2025 (1)
- December 2024 (2)
- November 2024 (1)
- September 2024 (1)
- August 2024 (1)
- July 2024 (1)
- May 2024 (1)
- March 2024 (1)
- February 2024 (1)
- January 2024 (1)
- December 2023 (3)
- November 2023 (2)
- September 2023 (2)
- August 2023 (2)
- July 2023 (1)
- June 2023 (1)
- March 2023 (2)
- December 2022 (3)
- November 2022 (1)
- July 2022 (1)
- December 2021 (1)
- August 2021 (1)
- July 2021 (1)
- June 2021 (1)
- April 2021 (1)
- February 2021 (1)
- December 2020 (1)
- November 2020 (2)
- October 2020 (2)
- September 2020 (1)
- July 2020 (1)
- June 2020 (1)
- May 2020 (1)
- January 2020 (3)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- June 2019 (2)
- April 2019 (1)
- March 2019 (1)
- December 2018 (2)
- October 2018 (1)
- July 2018 (1)
- May 2018 (1)
- March 2018 (1)
- January 2018 (2)
- October 2017 (1)
- August 2017 (2)
- June 2017 (5)
- May 2017 (2)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- December 2016 (1)
- October 2016 (2)
- September 2016 (1)
- August 2016 (1)
- July 2016 (1)
Search
88 result(s) found, displaying 51 to 75
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #12.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #11.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #10.
- Submissions in response to the Office of Drug Control's (ODCs) Consultation on Single Licence Model close COB Monday 3 February 2020.
- The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967.
- Report on the Review into the 2016 medicinal cannabis amendments to the Narcotic Drugs Act 1967 was tabled in Parliament on Thursday 5 September 2019.
- The Australian Government will boost the nation's medicinal cannabis industry by prioritising projects that have been granted Major Project Status (MPS) and ultimately driving economic growth.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #9.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #8.
- A clarification of the processing rules around the timing of a medicinal cannabis licence and narcotics manufacturing licences.
- Professor John McMillan AO appointed to review and report on the operation of the Narcotic Drugs Act 1967.
- The TGA will be hosting public meetings in February 2019 in Sydney, Brisbane and Melbourne.
- Correcting the record on the 5 December 2016 Australian Financial Review story.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #7.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #6.
- False and misleading claims made by some companies
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #5.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #4.
- Allowing the export of Australian-manufactured medicinal cannabis products.
- The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #3.
- Doctors wishing to prescribe unregistered medicinal cannabis products under SAS Cat A.
- Response to public consultation is now available.
- Office of Drug control is seeking feedback on the potential export of medicinal cannabis.
- The Australian Advisory Council on the Medicinal Use of Cannabis, Communique #2.
- The Office of Drug Control will be hosting two information and consultation sessions in July 2017.